October 15, 2021

INFINITE BOOST: FDA advisory panel to consider Johnson & Johnson COVID-19 booster dose.

Poor J&J. Any other time this vaccine would have been a world-beating triumph, but this time it’s been an also-ran, and now it’s losing its major selling point, one-and-done dosing.

InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.